Online cash-pay weight-treatment service

Ivy RX review

Ivy RX can suit someone who wants a straightforward remote prescription service and will use provider messaging when questions come up. I would judge it at the full selected payment, not the $77 opening card. The important catch is financial flexibility: automatic renewal and restrictive prescription-refund wording make it a poor choice for someone expecting a money-back trial.

See how the program works.

Look at the support, the ongoing commitment and what the price includes.

Visit Ivy RXOfficial provider website. No affiliate relationship is currently listed.

When it may fit

A buyer who can match the actual supply and recurring charge to their budget.

  • Clinical review, delivery and patient-platform communication are described.
  • The current GLP-1 card labels its starting price with a supply qualifier.
  • The public terms identify how recurring billing continues.

Where it falls short

Someone relying on a survey result or an assumed refund to make a long purchase feel low risk.

  • The headline does not establish every selected medication price.
  • Prescribed products cannot be returned.
  • The refund-request process is qualified and conflicts with stronger final-sale FAQ wording.
In this review

Start with the bill you would actually pay

Ivy RX currently shows personalized GLP-1 treatment from $77, with four doses per month beside the price. The page covers compounded semaglutide and tirzepatide, so that one number is not enough to budget every medicine or supply length. When weighing bmiMD’s prescription options against Ivy RX, ask both for a quote covering the same medicine and supply period, including the recurring charge before deciding that the service fits. [3]

The $69 microdose card is a separate catalogue offer, not a discount to apply to any treatment. Nor does a starting monthly label show whether the first payment covers one month or a larger term. A cheaper-looking figure is useful only when the actual supply and commitment are the ones you would choose. [4] [7]

Remote access still needs a usable clinical contact

The product advertises online clinical review, live support, a patient app and free temperature-controlled delivery. Its FAQ describes secure messaging to providers through the patient portal. Those can make a service practical for someone managing care from home. [3]

Same-day review does not mean every applicant receives a prescription that day, and fast delivery language is not an individual arrival guarantee. I would distinguish an administrative support response from a clinical answer and keep the expected follow-up clear. Convenience should make appropriate care easier to manage, rather than become the sole reason to buy it.

A partner pharmacy is part of the arrangement

Ivy’s general FAQ says the main prescription is fulfilled through specific partner pharmacies, not a pharmacy chosen freely by the buyer. Some medicines for weight-treatment side effects may be prescribed locally, but those are separately paid. That is an exception for a different bill, not unrestricted transfer of the principal prescription. [6]

The same FAQ says the service does not accept public or private insurance. Keep the cash-pay invoice distinct from any separate local prescription or possible reimbursement. A seller’s HSA/FSA or reimbursement language should not be treated as an insurer’s approval of a particular expense. [3] [6]

Know what renews after a prepaid term

The public terms describe one-month or three-month prepayment, followed by monthly automatic renewal unless canceled before the existing term ends. The agreement describes support cancellation and also portal plan management. When you compare upfront and recurring costs, ask for the next billing date and amount before choosing a prepaid term. [4]

Those linked terms display a March 2023 update date. They do not provide a current medication-specific invoice for every product or campaign. Keep the selected offer and written confirmation when stopping a future charge; do not assume that paying for three months once makes all later renewals three-month purchases. [4]

A request for a refund is not a trial guarantee

The refund page says products cannot be returned, and the general FAQ calls prescription transactions final. The terms separately permit a dissatisfaction refund request within fifteen days of the order, through the specified email channel and required subject, transaction and contact details. Approval is not promised. [4] [5] [6]

A dispensing concern should be raised through the stated support process. Ending future renewal, seeking help for a mistake and requesting a dissatisfaction refund are separate requests. I would avoid a larger commitment if recovering the money is what makes the purchase feel affordable.

Choose the service rather than the survey headline

Ivy’s reported weight-loss percentage is based on internal customer survey data. It does not predict a new patient’s result or establish a controlled comparison with another provider. Its compounded products also do not acquire FDA approval through a familiar ingredient name or a quality-testing claim. [3] [8]

Ivím is a useful comparison when structured support and a separate membership are appealing. Choose Ivy when the actual review, contact and delivery arrangement earn the selected bill, with the renewal and refund limits understood. The broader catalogue is not a reason to add treatments to a weight-care plan.

Understanding the cost

Current product page: GLP-1 from $77, labeled four doses/month; NAD+ and sermorelin from $179, use varies. Catalogue sermorelin shows $175, conflicting with its product page. Actual medicine, supplied amount, first paid term and renewal need a selected quote. Public terms describe one- or three-month prepayment followed by monthly renewal, not a universal invoice for every offer. [1] [2] [3] [4] [7]

Build your cost estimate

Sources

  1. Ivy RX: NAD+ injection starting price, inclusions and quality claims
  2. Ivy RX: sermorelin injection starting price, assessment and service claims
  3. Ivy RX: current personalized GLP-1 product, starting price and survey limitations
  4. Ivy RX: March 12, 2023 displayed terms, subscriptions, cancellation and fifteen-day refund requests
  5. Ivy RX: no-returns policy
  6. Ivy RX: December 23, 2024 general FAQ, partner pharmacies, final sales and self-pay
  7. Ivy RX: current catalogue prices and patient messaging description
  8. FDA: compounded drugs and premarket review

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.